Vanessa Fleury1,2, Pierre Pollak3,4, Julien Gere4,5, Giorgio Tommasi4,6, Luigi Romito4,7, Christophe Combescure8, Eric Bardinet9, Stephan Chabardes10, Shahan Momjian11, Alexandre Krainik12, Pierre Burkhard3, Jérôme Yelnik9, Paul Krack4,13. 1. Department of Neurology, Geneva University Hospital, Geneva, Switzerland. Vanessa.FleuryNissen@hcuge.ch. 2. Movement Disorder Unit, Department of Psychiatry and Neurology, Grenoble University Hospital, Grenoble, France. Vanessa.FleuryNissen@hcuge.ch. 3. Department of Neurology, Geneva University Hospital, Geneva, Switzerland. 4. Movement Disorder Unit, Department of Psychiatry and Neurology, Grenoble University Hospital, Grenoble, France. 5. Department of Neurology, Savoie Hospital, Chambery, France. 6. Department of Neurology, University Hospital of Verona, Verona, Italy. 7. Department of Neurology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy. 8. Department of Health and Community Medicine, Geneva University Hospital, Geneva, Switzerland. 9. Sorbonne Université, UPMC Univ Paris, Inserm U975, CNRS UMR 7225, Centre de Neuroimagerie de Recherche, Institut du Cerveau et de la Moelle Épinière, Paris, France. 10. Department of Neurosurgery, Grenoble University Hospital, Grenoble, France. 11. Department of Neurosurgery, Geneva University Hospital, Geneva, Switzerland. 12. US 017, INSERM, UMS 3552, CNRS, Grenoble University Hospital, Neuroradiology and MRI, Grenoble, France. 13. INSERM U836, University Grenoble Alpes, Grenoble Neuroscience Institute, Grenoble, France.
Abstract
BACKGROUND: Gait and akinesia deterioration in PD patients during the immediate postoperative period of DBS has been directly related to stimulation in the subthalamic region. The underlying mechanisms remain poorly understood. The aim of the present study was to clinically and anatomically describe this side effect. METHODS: PD patients presenting with a worsening of gait and/or akinesia following STN-DBS, that was reversible on stimulation arrest were included. The evaluation included (1) a Stand Walk Sit Test during a monopolar survey of each electrode in the on-drug condition; (2) a 5-condition test with the following conditions: off-drug/off-DBS, off-drug/on-best-compromise-DBS, on-drug/off-DBS, on-drug/on-best-compromise-DBS, and on-drug/on-worsening-DBS, which utilized the contact inducing the most prominent gait deterioration. The following scales were performed: UPDRSIII subscores, Stand Walk Sit Test, and dyskinesia and freezing of gait scales. Localization of contacts was performed using a coregistration method. RESULTS: Twelve of 17 patients underwent the complete evaluation. Stimulation of the most proximal contacts significantly slowed down the Stand Walk Sit Test. The on-drug/on-worsening-DBS condition compared with the on-drug/off-DBS condition worsened akinesia (P = 0.02), Stand Walk Sit Test (P = 0.001), freezing of gait (P = 0.02), and improved dyskinesias (P = 0.003). Compared with the off-drug/off-DBS condition, the on-drug/on-worsening-DBS condition improved rigidity (P = 0.007) and tremor (P = 0.007). Worsening contact sites were predominantly dorsal and anterior to the STN in the anterior zona incerta and Forel fields H2. CONCLUSIONS: A paradoxical deterioration of gait and akinesia is a rare side effect following STN-DBS. We propose that this may be related to misplaced contacts, and we discuss the pathophysiology and strategies to identify and manage this complication.
BACKGROUND: Gait and akinesia deterioration in PDpatients during the immediate postoperative period of DBS has been directly related to stimulation in the subthalamic region. The underlying mechanisms remain poorly understood. The aim of the present study was to clinically and anatomically describe this side effect. METHODS:PDpatients presenting with a worsening of gait and/or akinesia following STN-DBS, that was reversible on stimulation arrest were included. The evaluation included (1) a Stand Walk Sit Test during a monopolar survey of each electrode in the on-drug condition; (2) a 5-condition test with the following conditions: off-drug/off-DBS, off-drug/on-best-compromise-DBS, on-drug/off-DBS, on-drug/on-best-compromise-DBS, and on-drug/on-worsening-DBS, which utilized the contact inducing the most prominent gait deterioration. The following scales were performed: UPDRSIII subscores, Stand Walk Sit Test, and dyskinesia and freezing of gait scales. Localization of contacts was performed using a coregistration method. RESULTS: Twelve of 17 patients underwent the complete evaluation. Stimulation of the most proximal contacts significantly slowed down the Stand Walk Sit Test. The on-drug/on-worsening-DBS condition compared with the on-drug/off-DBS condition worsened akinesia (P = 0.02), Stand Walk Sit Test (P = 0.001), freezing of gait (P = 0.02), and improved dyskinesias (P = 0.003). Compared with the off-drug/off-DBS condition, the on-drug/on-worsening-DBS condition improved rigidity (P = 0.007) and tremor (P = 0.007). Worsening contact sites were predominantly dorsal and anterior to the STN in the anterior zona incerta and Forel fields H2. CONCLUSIONS: A paradoxical deterioration of gait and akinesia is a rare side effect following STN-DBS. We propose that this may be related to misplaced contacts, and we discuss the pathophysiology and strategies to identify and manage this complication.
Authors: Kévin Ahrweiller; J F Houvenaghel; A Riou; S Drapier; P Sauleau; C Haegelen; P Jannin; M Vérin; X Palard; F Le Jeune Journal: J Neurol Date: 2019-07-26 Impact factor: 4.849
Authors: Daniel Weiss; Anna Schoellmann; Michael D Fox; Nicolaas I Bohnen; Stewart A Factor; Alice Nieuwboer; Mark Hallett; Simon J G Lewis Journal: Brain Date: 2020-01-01 Impact factor: 13.501
Authors: Zachary J Conway; Peter A Silburn; Wesley Thevathasan; Karen O' Maley; Geraldine A Naughton; Michael H Cole Journal: Mov Disord Clin Pract Date: 2018-11-08
Authors: Sara J Hanrahan; Joshua J Nedrud; Bradley S Davidson; Sierra Farris; Monique Giroux; Aaron Haug; Mohammad H Mahoor; Anne K Silverman; Jun Jason Zhang; Adam Olding Hebb Journal: Brain Sci Date: 2016-11-29
Authors: Tao Xie; Mahesh Padmanaban; Lisa Bloom; Ellen MacCracken; Breanna Bertacchi; Abraham Dachman; Peter Warnke Journal: Transl Neurodegener Date: 2017-05-17 Impact factor: 8.014
Authors: Karlo J Lizarraga; Corneliu C Luca; Antonio De Salles; Alessandra Gorgulho; Anthony E Lang; Alfonso Fasano Journal: Surg Neurol Int Date: 2017-10-24